rs2229470

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_004613.4(TGM2):​c.1170G>A​(p.Ala390Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00828 in 1,614,164 control chromosomes in the GnomAD database, including 107 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0069 ( 12 hom., cov: 32)
Exomes 𝑓: 0.0084 ( 95 hom. )

Consequence

TGM2
NM_004613.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -3.36

Publications

9 publications found
Variant links:
Genes affected
TGM2 (HGNC:11778): (transglutaminase 2) Transglutaminases are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. While the primary structure of transglutaminases is not conserved, they all have the same amino acid sequence at their active sites and their activity is calcium-dependent. The protein encoded by this gene acts as a monomer, is induced by retinoic acid, and appears to be involved in apoptosis. Finally, the encoded protein is the autoantigen implicated in celiac disease. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TGM2 Gene-Disease associations (from GenCC):
  • type 2 diabetes mellitus
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 20-38139584-C-T is Benign according to our data. Variant chr20-38139584-C-T is described in ClinVar as Benign. ClinVar VariationId is 770468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.36 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00842 (12302/1461892) while in subpopulation MID AF = 0.0307 (177/5768). AF 95% confidence interval is 0.027. There are 95 homozygotes in GnomAdExome4. There are 6274 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 1056 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGM2NM_004613.4 linkc.1170G>A p.Ala390Ala synonymous_variant Exon 9 of 13 ENST00000361475.7 NP_004604.2 P21980-1V9HWG3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGM2ENST00000361475.7 linkc.1170G>A p.Ala390Ala synonymous_variant Exon 9 of 13 1 NM_004613.4 ENSP00000355330.2 P21980-1
TGM2ENST00000468262.5 linkn.1254G>A non_coding_transcript_exon_variant Exon 9 of 10 1
ENSG00000293724ENST00000718567.1 linkn.121C>T non_coding_transcript_exon_variant Exon 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.00696
AC:
1059
AN:
152154
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00224
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00641
Gnomad ASJ
AF:
0.0360
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00931
Gnomad FIN
AF:
0.00311
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.00923
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.00867
AC:
2181
AN:
251448
AF XY:
0.00909
show subpopulations
Gnomad AFR exome
AF:
0.00160
Gnomad AMR exome
AF:
0.00555
Gnomad ASJ exome
AF:
0.0390
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00203
Gnomad NFE exome
AF:
0.00939
Gnomad OTH exome
AF:
0.0122
GnomAD4 exome
AF:
0.00842
AC:
12302
AN:
1461892
Hom.:
95
Cov.:
31
AF XY:
0.00863
AC XY:
6274
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.00176
AC:
59
AN:
33480
American (AMR)
AF:
0.00597
AC:
267
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0362
AC:
947
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0119
AC:
1024
AN:
86258
European-Finnish (FIN)
AF:
0.00217
AC:
116
AN:
53420
Middle Eastern (MID)
AF:
0.0307
AC:
177
AN:
5768
European-Non Finnish (NFE)
AF:
0.00813
AC:
9041
AN:
1112010
Other (OTH)
AF:
0.0111
AC:
670
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
777
1554
2330
3107
3884
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00693
AC:
1056
AN:
152272
Hom.:
12
Cov.:
32
AF XY:
0.00662
AC XY:
493
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00224
AC:
93
AN:
41550
American (AMR)
AF:
0.00634
AC:
97
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0360
AC:
125
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00911
AC:
44
AN:
4828
European-Finnish (FIN)
AF:
0.00311
AC:
33
AN:
10604
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.00923
AC:
628
AN:
68018
Other (OTH)
AF:
0.0128
AC:
27
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
50
101
151
202
252
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0112
Hom.:
8
Bravo
AF:
0.00686
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.0113
EpiControl
AF:
0.0138

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TGM2: BP4, BP7, BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.094
DANN
Benign
0.49
PhyloP100
-3.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229470; hg19: chr20-36767986; API